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Summary
Objective: To characterize the expression pattern of clusterin in adult human normal and osteoarthritic cartilage.
Methods: Clusterin mRNA expression in adult human normal and osteoarthritic cartilage was investigated by analysis of cDNA libraries,
TaqMan quantitative RT-PCR, microarray and in situ hybridization.
Results: Sequence analysis of ESTs from adult human normal and osteoarthritic cartilage cDNA libraries demonstrated that the abundance
of clusterin in these libraries was equivalent to genes which have been more commonly associated with cartilage. To examine tissue
distribution, TaqMan Quantitative PCR analysis was performed using RNA from a panel of individual normal tissues. Clusterin was expressed
at significant levels in cartilage, brain, liver, and pancreas. The expression of clusterin mRNA was up-regulated in early osteoarthritic vs
normal cartilage when analysed by microarray analysis. Using in situ hybridization, chondrocytes of normal cartilage expressed moderate
levels of clusterin. Upper mid-zone chondrocytes in cartilage with early stages of osteoarthritic disease expressed high levels of clusterin
mRNA. In advanced osteoarthritic cartilage, the overall expression of clusterin was reduced.
Conclusion: The induction of clusterin has been associated with a variety of disease states where it appears to provide a cytoprotective
effect. The increased expression of clusterin mRNA in the early stages of osteoarthritis (OA) may reflect an attempt by the chondrocytes to
protect and repair the tissue. In contrast, the decrease in clusterin mRNA in the advanced osteoarthritic cartilage accompanies the final
degenerative stages of the disease. An understanding of the expression of clusterin in osteoarthritis may allow consideration of this protein
as a marker for cartilage changes in this chronic degenerative condition. © 2001 OsteoArthritis Research Society International
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Clusterin, a secreted heterodimeric glycoprotein, is pro-
duced by many tissues and is associated with a wide
variety of biological activities1–3. Clusterin is also known as
testosterone repressed prostate message 2 (TRPM-2),
cytolysis inhibitor (CLI), SP-40,40, apolipoprotein J, gp80,
NA1/NA2, clone pADHC-9, and SGP-2. The protein is often
dramatically induced in disease states such as neuro-
degenerative disorders (Alzheimer’s disease), athero-
sclerosis, myocardial infarction, glomerulonephritis,
polycystic kidney disease, and renal tubular injury1,3.
Additionally, clusterin mRNA is increased during hormone
induced tissue remodelling, or by cytotoxic chemicals or
developmental stimuli1. Clusterin appears to play a role in
diverse biological processes including inhibition of the
terminal cytolytic complement cascade, lipid transport,
apoptosis, spermatozoa maturation and response to tissue
injury. Interestingly, there is a high degree of conservation– –
727among various species orthologues. The region of nucleic
acid residues 87–150 shares 98% identity across species,
which suggests that it has an essential functional role.
Together these data suggest that clusterin may perform a
common essential physiologic function across diverse
organs in multiple species.
Although clusterin has been shown to be expressed in
many tissues, it is not expressed by all cells in those
tissues. Its pattern of distribution has been demonstrated to
be very specific. In many instances, cells which line fluid–
tissue interfaces express clusterin3. The expression of
clusterin mRNA at fluid–tissue interfaces has been demon-
strated in cells by in situ hybridization in epithelial boundary
cells of a variety of mouse and human tissues and in
non-epithelial cell types—synovial lining cells and ovarian
granulosa cells. Given the known biological activities of
clusterin, these data suggested that clusterin provides a
protective effect for the cells exposed to tissue damaging
agents present in extracellular fluids4.
Although the varied tissue distribution of clusterin has
been described, the expression of clusterin by chondro-
cytes in human articular cartilage has not been described
previously. Two reports have associated clusterin with
degenerative joint diseases. In a study of terminal com-
plement activation and lysis inhibitors, complement C5a
concentrations were elevated in plasma and synovial fluids
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TISSUE PROCESSING
Adult human articular osteoarthritic cartilage was
obtained with informed consent from patients undergoing
joint replacement surgery for OA. Normal, early and
advanced osteoarthritic articular cartilage was obtained
from the Anatomical Gift Foundation (Laurel, MD). The
disease state of the cartilage was characterized by the
following histological criteria: (a) normal cartilage had a
smooth, intact superficial zone and no indication of proteo-
glycan loss (as determined by Safranin-O staining) from the
mid- or deep zones; (b) early OA damage included slight
fissuring of the superficial zone and loss of proteoglycan
from the zones immediately surrounding the chondrocytes
in the mid- and deep zones; (c) advanced osteoarthritic
cartilage included deep and extensive fissuring of the
superficial zone with characteristic cloning of chondrocytes
and extensive proteoglycan loss throughout the mid- and
deep zones. For RNA preparation, cartilage was snap-
frozen in liquid nitrogen and stored at −80°C. For histologi-
cal and in situ hybridization analyses, the cartilage was
coated in a 5% solution (w/v) of polyvinyl alcohol (PVA) and
and then chilled (−70°C) by precipitate immersion in cooled
n-hexane. Cryostat sections (5 m) of unfixed, undecalci-
fied cartilage were cut on a modified Hacker cryostat
equipped with a finely polished tungsten-tipped steel knife
and collected on to 3-aminopropyltriethoxy silane coated
slides.HISTOLOGICAL STAINING
Serial sections were stained with a modified aqueous
Romanowsky Wright stain (fast green in methanol, eosin G
and methylene blue/azure A; Baxter Scientific). Sections
were fixed for 30 s in fast green/methanol and dipped
directly into the eosin for 30 s. Sections were then stained
directly with methylene blue/azure A for 1 min washed indistilled water, air dried and mounted in DPX mountant
(BDH Laboratory Supplies, Poole, U.K.).SAFRANIN-O STAINING
Serial sections were stained for proteoglycan content
using Safranin-O by the method of Kiviranta et al.6. Briefly,
sections were dipped in 1% acetic acid and stained with
0.2% (w/v) Fast Green, rinsed in 1% acetic acid and
counterstained in 0.1% Safranin-O. Finally, sections were
dehydrated through 100% ethyl alcohol and cleared in
xylene then mounted in synthetic resin.EXTRACTION AND PURIFICATION OF CARTILAGE TOTAL RNA
Total RNA was extracted from cartilage by a modified
method of Adams et al.7, as follows. Fresh cartilage tissue
was frozen immediately in liquid nitrogen and stored at
−80°C prior to extraction. Frozen cartilage (0.5–1.0 g) was
powdered in a Spex Freezer Mill (SPEX, Metuchen, NJ)
and immediately homogenized in 4 ml of 4 M guanidinium
isothiocyanate solution (Life Technologies, Gaithersburg,
MD) with 2.5 l of 2-mercaptoethanol. The extracts were
centrifuged at 1500 g for 10 min at 4°C and the supernatant
was transferred to a separate tube. The extraction of the
pellet was repeated and the supernatants were pooled.
Triton X-100 (0.65 ml of 25%) was added to the super-
natants which were mixed and incubated on ice for 15 min.
Sodium acetate (8.0 ml of 3 M at pH 6.0) was added, mixed
and incubated on ice for 15 min. The supernatants were
extracted with 12 ml phenol (DEPC-water saturated; acidic)
and 3 ml chloroform/isoamyl alcohol (49:1), mixed and
incubated on ice for 10 min, then centrifuged at 15,000 g
for 20 min. The extraction and separation of the aqueous
phase was repeated twice with 10 ml phenol and 10 ml
chloroform/isoamyl alcohol (49:1). The RNA in the aqueous
phase was precipitated with 0.8 volumes of isopropanol on
ice for 5 min followed by centrifugation at 15,000 g for
30 min. The pellet was dissolved in 0.9 ml of lysis buffer
RLT (Qiagen RNeasy kit, Qiagen, Chatsworth, CA) then
0.9 ml of 70% ethanol was added and mixed by inversion.
The solution was applied to an RNeasy Spin column by
centrifugation at 8000 g for 25 s. The column was washed
with 0.7 ml of wash buffer RW1 and centrifuged at 8000 g
for 25 s. The column was placed into a new collection tube
and washed with buffer RPE (0.5 ml) and centrifuged at
8000 g for 25 s. The final wash was with 0.5 ml of buffer
RPE with centrifugation at 14,000 rpm for 2 min. The col-
umn was transferred to a new collection tube and the RNA
was eluted with 50 l of nuclease-free water followed by
centrifugation at 8000 g for 1 min. The concentration and
purity of the RNA were determined by spectrophoto-
metric analysis and structural integrity was confirmed by
electrophoresis.
Due to the limited amount of cartilage tissue available
from each sample for RNA extraction, RNA samples were
pooled to provide the required quantities of RNA for the
various analyses described in the following sections. The
distinct and specific composition of each pooled sample is
described in the appropriate sections below.cDNA LIBRARY CONSTRUCTION
Total RNA from human normal (three patients, age range
31–45 years) and osteoarthritic (5 patients, age rangeof patients with rheumatoid arthritis (RA) compared with
those with osteoarthritis (OA), whereas clusterin concen-
trations were similar between the groups5. More impor-
tantly, the same study demonstrated that the levels of
clusterin protein were reduced in both groups relative to
albumin levels, suggesting that the chondrocytes would be
more susceptible to lytic attack and damage by mediators
of joint destruction. In the second report, the expression of
clusterin mRNA in synovial lining cells from a single speci-
men of human hip joint by in situ hybridization was
described4.
This paper describes, for the first time, the expression of
clusterin in adult human normal and osteoarthritic articular
cartilage. By in situ hybridization, the expression of clus-
terin mRNA was most intense in the superficial zone
chondrocytes of early osteoarthritic cartilage compared
with normal cartilage. In cartilage with advanced OA, clon-
ing chondrocytes and upper mid-zone chondrocytes also
expressed clusterin mRNA, but at reduced levels com-
pared to early OA. The abundance of clusterin mRNA was
elevated also in early osteoarthritic cartilage compared with
normal cartilage when analysed by ATLAS blot and micro-
array analysis. The data suggest that the chondrocytes in
early OA may enter a protective phase to slow the loss of
articular cartilage.
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section and submitted to BioServe Technologies, Inc.
(Laurel, MD) for preparation of poly A+ mRNA and oligo dT
primed, directional cDNA library construction in the Sal I
and Not I restriction sites of the pSPORT 1 vector. The
cDNA libraries were not manipulated by amplification,
normalization or subtraction.DNA SEQUENCING
Bacterial clones were grown on agar plates and colonies
were picked by Q-Bot robot (Genetix). Template DNA for
sequencing was prepared using a Biorobot 9600 (Qiagen).
More than 5000 clones were sequenced from each library.
Automated cycle sequencing reactions were performed
using Applied Biosystems’ standard sequencing protocols
for the BigDye terminator chemistry and using the ABI 377
automated sequencing system (Applied Biosystems-
division of Perkin-Elmer corporation, Foster City, CA).SEQUENCE ANALYSIS
For each library, the EST sequences were subjected to
an assembly process whereby overlapping EST sequences
(presumably belonging to the same genes) were joined into
extended, contiguous sequences (assemblies). The first
step of the assembly process involved trimming of unin-
formative regions such as vector and polylinker sequences,
regions of low quality sequence, contaminants (e.g. E. coli
simple tandem repeats), Alu and other repeats, and poly-A
and poly-T regions. In the next step, trimmed EST
sequences, along with all other EST sequences derived
from other sources (public and proprietary), were joined
into continguous assemblies subject to the condition that
the ESTs shared an overlapping region of at least 40
nucleotides with 90% or better identity. Characterization
and annotation of the assemblies was achieved by
sequence comparison to other known proteins, and supple-
mented by signature motif searches of known protein
families. To assess the relative expression pattern (up- vs
down-regulation) of a particular gene product (assembly)
common in the two libraries, the relative abundance level of
the assembly in the two libraries was compared. In
essence, the abundance level of a particular assembly in a
library is a measure of its contribution to the total mRNA in
that library, and is calculated by dividing the number of
primary EST components in that assembly which are
derived from the library divided by the total number of
primary ESTs in the library. Under this scheme, for
example, an assembly with an abundance level of 0.001
indicates that 0.1% of the total ESTs of the library are
components of that particular assembly, and an assembly
which is supposed to be 2-fold up-regulated in the osteo-
arthritic vs normal cartilage library would have an abun-
dance level in the osteoarthritic library twice that in normal
cartilage library.TAQMAN QUANTITATIVE PCR ANALYSISGeneration of samples for TaqMan mRNA analysis
Human tissue (non-cartilaginous) or RNA was pur-
chased (Biochain, San Leandro, CA; Invitrogen, Leek,
The Netherlands; Clontech, Palo Alto, CA) or donated
(Netherlands Brain Bank, Amsterdam, The Netherlands)and poly A+ RNA was prepared by the PolyATract method
according to manufacturers instructions (Promega, USA)8.
Normal articular cartilage was obtained at the time of
autopsy (Anatomic Gift Foundation, Laurel, MC) from four
individuals (age range 21–66 years old) with no evidence of
gross or histological disease and total RNA was extracted
as described in the previous section. The poly A+ RNA
samples from 20 body tissues from four individuals per
tissue (two males/two females) were quantitated using
OD260 nm measurement or the RiboGreen fluorescent
method (Molecular Probes, Oregon, U.S.A.) and 1 g
of each RNA was reverse transcribed using random
nonamers and Superscript II reverse transcriptase accord-
ing to manufacturers instructions (Life Technologies). The
cDNA prepared was diluted to produce up to 1000 replicate
96-well plates using Biomek robotics (Beckman Coulter,
High Wycombe, U.K.), so that each of the wells contained
the cDNA produced from 1 ng RNA for the appropriate
tissue. The 96-well plates were stored at −80°C prior to
use.TaqMan PCR
TaqMan quantitative PCR was conducted to measure
either clusterin or housekeeping genes using replicate 96-
well plates. A 20-l volume of a PCR master mix [containing
2.5 l TaqMan buffer, 6 l 25 mM MgCl2, 0.5 l of 10 mM
dATP, 0.5 l of 20 mM dUTP, 0.5 l of 10 mM dCTP, 0.5 l
of 10 mM dGTP, 0.25 l Uracil-N-glycosylase, 1 l of 10 M
forward primer, 1 l of 10 M reverse primer, 0.5 l 5 M
TaqMan probe, 0.125 l TaqGold (PE Biosystems), 6.625 l
water] was added to each well using Biomek robotics
(Beckman Coulter, High Wycombe, U.K.), and the plate
capped using optical caps (PE Biosystems). The PCR
reaction was carried out on an ABI7700 Sequence Detector
(PE Biosystems) using the PCR parameters: 50°C for
2 min, 95°C for 10 min and 45 cycles of 94°C for 15 s, 60°C
for 1 min, and the level of mRNA-derived cDNA in each
sample was calculated from the TaqMan signal using
plasmid/genomic DNA calibration standards included in
each run. The level of genomic DNA contaminating the
original RNA samples was shown to be negligible (<10
copies genomic DNA/ng RNA) by TaqMan measurement of
genomic sequence for ten genes in replicate samples taken
through the reverse transcription procedure described
with the omission of reverse transcriptase. Gene-specific
reagents for clusterin: forward primer 5′-GCTCAGCAGGC
CATGGACAT-3′, reverse primer 5′-TCGTATGAATTCTGT
TGGCGG-3′, TaqMan probe 5′-CACTTCCACAGCCCGG
CCTTCC-3′; B-actin forward primer 5′-GAGCTACGAGCT
GCCCGATG-3′, reverse primer 5′-GTAGTTTCGTGGATG
CCACAGGACT-3′, TaqMan probe 5′-CATCACCATTGGCA
ATGAGCGGTTTCC-3′.MICROARRAY ANALYSIScDNA microarrays
Gene expression patterns were assessed using cDNA
microarrays consisting of robotically spotted PCR ampli-
cons on Nylon membranes (Schleicher and Schuell Nytran
Plus)9. In brief, 1536 human cDNA clones were cultured
in 96-well format and plasmid DNA was prepared using
Qiagen REAL kits (QIAGEN Inc., Valencia, CA, cat.
#28183). Plasmids were resuspended in TE buffer, and
rearrayed in 384-well plates. Arrays were printed onto
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Membranes were placed on top of two pieces of blotting
paper (S&S GB002) saturated with denaturing solution
(0.5 M NaOH, 1.5 M NaCl), and placed within a 96-well
plate lid. Membranes were spotted at approximately
100 ng/l of plasmid DNA. The spotting plates consisted of
7 l DNA (300 ng/l) and 14 l of denaturing solution, for a
total starting volume of 21 l. Filters were then transferred
to Whatman 3 M paper that was saturated with denaturing
solution for 5 min, followed by a similar treatment with
neutralization buffer (0.5 M Tris pH 7.5, 1.5 M NaCl). Filters
were rinsed briefly in distilled water to remove excess
salts and then UV cross-linked using the autocross setting
on a Stratagene Stratalinker. Membranes were stored
dessicated.Labeling and hybridizations
Total RNA from normal (three patients, age range 31–75)
and early osteoarthritic (four patients, age range 42–71)
cartilage was prepared as previously described. For each
array hybridization, labeled cDNA was synthesized by
reverse transcription from 20 g of total RNA in the pres-
ence of 33P dDTP (Amersham). Reverse transcription was
performed using the LTI Superscript II PreAmplification
Kit (Life Technologies, cat no. 18089-011) as described
by the manufacturer. Probes were purified on Clontech
Chromaspin 30 columns.
Membranes were rehydrated in distilled water and
placed in plastic boxes for prehybridization in 12 ml/filter
Church buffer (1% BSA, 1 mM EDTA, 0.5 M NaPO4,
pH 7.5, 7% SDS) at 65°C for 1 h to overnight. Fresh
Church buffer and probe were added to the blots which
were hybridized with shaking at 65°C for 16 h.
Filters were washed with 2×SSC, 0.1% SDS at 65°C for
15 min with shaking, and then with 0.2×SSC, 0.1% SDS
65°C for 15 min. Membranes were sealed in Saran wrap,
and exposed to Molecular Dynamics PhosphorImager
screens for 1–72 h, depending on the activity of the probe,
and then scanned.Array imaging and quantitation
Scanned images were quantitated using MCID software
by Imaging Research (now Amersham Arrayvision). Data
was normalized by a procedure that divided the raw value
for each spot by the sum of the values for all spots on the
grid, and then multiplied by the total number of spots on the
grid. The intensity for each spot was then reported as its
proportion of total expression. This allowed comparison of
data across experiments, and greatly reduced artifacts due
to probe activity. Background was subtracted before the
normalization. Data was interrogated using Excel, the
Imaging Research software, and Spotfire Pro II.ATLAS HUMAN cDNA EXPRESSION ARRAY (CLONTECH)
Total RNA was isolated from normal (three patients, age
range 63–79) and early osteoarthritic (three patients, age
range 71–93) cartilage. PolyA+ RNA was then extracted
using Dynabeads Oligo(dT)25 (Dynal A.S., Norway) accord-
ing to vendor’s recommendation. 32P cDNA probes were
synthesized from each PolyA+ RNA using MMLV as
the reverse transcriptase, purified by NucTrap Probe
Purification Columns (Stratagene) and used to hybridizetwo Atlas Human cDNA Expression Arrays (Clontech)
according to manufacturer’s protocol.RNA PROBES
The cloning and amplification of DNA fragments
of human clusterin for riboprobe preparation was
accomplished as follows: two pairs of primers were
designed according to the published cDNA sequence of
human clusterin. The sequences for the first pair were:
5′-TAATACGACTCACTATAGGGCGAAGCACCCGCCAAC
AGAATTCATA-3′ (1–23, T7 promoter sequence; 24–46,
clusterin, sense) and 5′-GCGGTATTCCTGCAGCGCT
TTCT-3′ (clusterin, antisense). The sequences for the
second pair were: 5′-AGCACCCGCCAACAGAATTC
ATA-3′ (clusterin, sense) and 5′-ATTTAGGTGACACTATAG
AATACGCGGTATTCCTGCAGCGCTTTCT-3′ (1–23, SP6
promoter sequence; 24–46, clusterin, antisense). PCRs
were performed using human heart Quick-Clone cDNA
(Clontech) such that the product contained a T7-linked
clusterin cDNA for use in sense RNA transcription and a
SP6-linked clusterin cDNA for use in antisense RNA tran-
scription. Each PCR products were confirmed by DNA
sequencing. Riboprobes were prepared using the Promega
(Madison, WI) in vitro transcription kit with 35S-thio CTP
(Amersham, Arlington Heights, IL). Following transcription,
cDNA templates were digested with RQ1 RNAse-free
DNAse I (Promega, Madison, WI) and unincorporated
nucleotides were removed by centrifugation through Quick
Spin Sephadex G-50 columns (Boehringer-Mannheim,
Indianapolis, IN). RNA transcripts with a specific activity in
excess of 108 cpm/mg were used for hybridization.IN SITU HYBRIDIZATION
In situ hybridization was performed by the original
method of Zeller and Rogers10 with modifications detailed
by Dodds et al.11. A total of 23 (patient ages 15–73 years)
human articular cartilage samples from normal (N=5), early
osteoarthritic (N=8) or advanced osteoarthritic (N=10) dis-
ease states were analyzed. Briefly, cryosections were fixed
in 4% paraformaldehyde, washed, dehydrated and frozen
at −20°C. Prior to hybridization, sections were hydrated,
demineralization and acetylated. Hybridization was carried
out at 42°C for 4 h and post-hybridization washes were to a
final stringency of 0.1×SSC. Sections were dehydrated, air
dried and coated in Amersham LM-1 emulsion. Following
exposure at 4°C for 2 weeks, the slides were developed in
Kodak developer and counterstained with methylene blue.
The extent of the hybridization signal was assessed by the
autoradiographic grain density over the cell and was scored
in a range from ± through + + + + for just over background
levels through intense levels of expression.ResultsPREPARATION, SEQUENCING AND ANALYSIS OF ADULT HUMAN
NORMAL AND OSTEOARTHRITIC ARTICULAR CARTILAGE cDNA
LIBRARIES
Adult human articular cartilage was collected, scored
based on gross pathology and histological examination and
divided into normal or osteoarthritic cartilage. Total RNA,
and subsequently poly A+ RNA, isolated from pooled
normal and osteoarthritic cartilage was used to generate
Osteoarthritis and Cartilage Vol. 9, No. 8 731cDNA libraries in the pSPORT1 vector. The cDNA libraries
were not manipulated by amplification, normalization or
subtraction. The normal and OA cDNA libraries contained
approximately 16×106 and 7×106 independent clones,
respectively. Both libraries contained an average insert size
of 1.3–1.5 Kb and the range varied between 0.3 and
4.2 Kb. These data suggested a very high quality and
broad coverage of gene expression in these libraries.
To analyse the global gene expression profile in normal
and osteoarthritic cartilage, approximately 5000 random
ESTs from each library were sequenced. To aid in analysis
of expressed genes, overlapping ESTs were grouped into
assemblies that represented virtual genes and compared
against public gene databases12. Collectively, the data
indicated that about 4–6% of the assemblies coded for
genes which have been reported previously to be
expressed abundantly in cartilage tissue and therefore
confirmed the authenticity of the tissue used for the
preparation of the cDNA libraries.
A small number of assemblies from both libraries
code for genes that are well characterized but whose
expression has not yet been localized to cartilage, including
clusterin, plasma glutathione peroxidase, and superoxide
dismutase. Clusterin was particularly interesting because
it was abundantly expressed in both libraries (average
1.7%) based on sequencing, at a level which was com-
parable to genes commonly associated with cartilage such
as decorin (3.6%), cartilage oligomeric protein (COMP,1.5%) and aggrecan (1.0%)12. Additionally, it had pre-
viously been reported to play a role in protection of cell
integrity.TAQMAN QUANTITATIVE PCR ANALYSIS OF CLUSTERIN
EXPRESSION IN NORMAL HUMAN TISSUES
The expression of clusterin was analysed in a panel of
four individual (two male and two female) samples of
20 normal human tissues by TaqMan quantitative PCR
(Fig. 1). Clusterin was expressed at high levels in normal
human brain, liver, adipose, pancreas and cartilage. The
high expression in these tissues was detected in all four
individuals tested, which is a requirement for confident
interpretation of tissue-specific expression. These data
confirm the high expression levels of clusterin detected in
the cartilage cDNA libraries.0
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Fig. 1. TaqMan quantitative PCR analysis of clusterin mRNA expression in normal human tissues. The poly A+ RNA from 20 normal tissues
from four individuals per tissue (two males and two females) were analysed for the expression of clusterin (A) or GAPDH (B). The data was
expressed as copies of gene’s mRNA detected per ng mRNA. Clusterin was detected at high levels in normal human cartilage, brain, liver,
adipose and pancreas. Note: muscle=1.2×106±0.37×106.MICROARRAY ANALYSIS OF CLUSTERIN EXPRESSION IN NORMAL
AND EARLY OSTEOARTHRITIC CARTILAGE
Total RNA from normal and early osteoarthritic cartilage
(graded histologically) samples was pooled, labeled and
hybridized to a microarray of 1536 human genes. The
quantitative analysis of hybridization intensities was com-
pared for various genes between the normal vs the early
732 J. R. Connor et al.: Clusterin expression in human cartilageosteoarthritic cartilage. By this method of analysis, clusterin
was detectable in normal cartilage RNA and its expression
was upregulated 1.21 fold in early osteoarthritic cartilage
compared to normal (shown in Table I). Additional genes
which were up-regulated in osteoarthritic cartilage and
which have been associated previously with cartilage were
HC gp-39, CTGF, -1 collagen type I, and FRZB precursor
(Table I). Genes which were down-regulated in early
osteoarthritic cartilage included fibronectin, cystatin C,
c-fos, vacuolar ATPase, TIMP, annexin II, osteonectin and
cathepsin K (Table I). This may suggest a cytoprotective
role which has been demonstrated for clusterin in other
disease states.ATLAS HUMAN cDNA EXPRESSION ARRAY
Two commercial replicate human cDNA expression
arrays (Clontech) were hybridized with 32P cDNA probes
which were synthesized from normal or early osteoarthritic
cartilage polyA+ RNA. As shown in Fig. 2, the expression
of clusterin mRNA was detectable in both normal and early
osteoarthritic cartilage and it was up-regulated (6.5 fold) in
early osteoarthritic cartilage. Although the relative magni-
tude of the increase in early OA is different (1.2 vs 6.5 fold)
when evaluated using the microarray vs the ATLAS blot,
both analyses suggest that clusterin expression is
increased in early OA relative to control normal tissue.Table I
Microarray analysis of gene expression in early osteoarthritic vs
normal human articular cartilage
Up-regulated genes Fold
increase
Down-regulated
genes
Fold
decrease
Clusterin 1.21 Fibronectin 1.72
HC gp39 1.99 TIMP 1.69
CTGF 4.72 Cystatin C 1.98
-1 collagen type 1 1.67 c-fos 5.04
FRZB precursor 4.64 Vacuolar ATPase 3.35
Annexin II 1.91
Osteonectin 1.51
Cathepsin K 1.62Fig. 2. Clusterin expression was elevated in early OA relative to normal human articular cartilage. Two commercial replicate human cDNA
expression arrays were hybridized with 32P cDNA probes synthesized from normal or early osteoarthritic cartilage. The expression of
clusterin mRNA was detectable in both normal and early osteoarthritic cartilage where its expression was up-regulated.EXPRESSION OF CLUSTERIN mRNA IN CHONDROCYTES OF
NORMAL AND OSTEOARTHRITIC HUMAN ARTICULAR CARTILAGE BY
IN SITU HYBRIDIZATION
The expression of clusterin mRNA in normal, early and
advanced osteoarthritic articular cartilage was analysed by
in situ hybridization in a total of 23 patient (age range
15–73 years) samples. Data from representative patient
samples at different stages of disease are shown in Table
II, where the extent of the hybridization signal was
assessed by the autoradiographic grain density over the
chondrocytes in a minimum of ten fields at 200× magnifi-
cation and was scored in a range from ± through + + + + for
just over background levels through intense levels of
expression.
Osteoarthritis and Cartilage Vol. 9, No. 8 733Table II
ISH analysis of clusterin mRNA expression in human articular cartilage
Cartilage Safranin-O Cell type ISH*
Normal No proteoglycan loss Superficial zone chondrocytes ±
Mid-zone chondrocytes + to + +
Deep zone chondrocytes ±
Normal No proteoglycan loss Superficial zone chondrocytes ± to +
Mid-zone chondrocytes ±
Deep zone chondrocytes ±
Very early OA Proteoglycan loss in superficial & deep zone; no fissuring Superficial zone chondrocytes
Mid-zone chondrocytes
Deep zone chondrocytes
+ to + +
+ +
±
Early OA Proteoglycan loss in superficial zone; mild fissuring Upper mid-zone chondrocytes
Lower mid-zone chondrocytes
Deep zone chondrocytes
+ + to + + +
+ +
±
Advanced OA Proteoglycan loss with cloning Upper mid-zone cloning chondrocytes
Upper mid-zone chondrocytes
Lower mid-zone chondrocytes
Deep zone chondrocytes
+
±
−
−
Advanced OA Severe proteoglycan loss through mid-zone; deep fissuring; cloning Upper mid-zone cloning chondrocytes
Upper mid-zone chondrocytes
Lower mid-zone chondrocytes
Deep zone chondrocytes
+
+
−
−
*The extent of the hybridization signal was assessed by the autoradiographic grain density over the cell and was scored in a range from
± through + + + + for just over background levels through intense levels of expression.Fig. 3. Analysis of clusterin mRNA expression in chondrocytes of normal human articular cartilage by in situ hybridization. Cryostat
sections were hybridized with 35S-labeled clusterin antisense (A) or sense (B) strand riboprobe and counterstained with methylene blue.
(A) Chondrocytes of normal cartilage expressed low to moderate levels of clusterin. Magnification ×200.Normal adult human articular cartilage was character-
ized by a smooth, intact superficial zone with no indication
of proteoglycan loss. There was a low to moderate level of
clusterin mRNA expression in the superficial zone chondro-
cytes (Fig. 3). Mid- and deep zone chondrocytes had
similar levels of clusterin mRNA expression (Table II).In contrast, early osteoarthritic cartilage had a mild degree
of fissuring, and detectable proteoglycan loss. Intense
expression of clusterin mRNA was observed in the upper
mid- zone chondrocytes [Fig. 4(a), (b)]. The lower mid-zone
chondrocytes also had high levels of expression while the
deep zone chondrocytes had lower expression (Table II).
734 J. R. Connor et al.: Clusterin expression in human cartilageFig. 4. Analysis of clusterin mRNA expression in chondrocytes of early and advanced osteoarthritic human articular cartilage by in situ
hybridization. Cryostat sections were hybridized with 35S-labeled clusterin antisense (A)–(D) and counterstained with methylene blue. (A) In
cartilage with early osteoarthritic disease, chondrocytes (arrowheads) expressed high levels of clusterin mRNA. Magnification ×200. (B)
Intense expression of clusterin was demonstrated in the upper mid-zone chondrocytes in early osteoarthritic cartilage. Magnification ×400.
(C) In chondrocytes of advanced osteoarthritic cartilage, clusterin mRNA expression was low in the upper mid-zone and negligible in the
lower mid-zone and deep zones. Magnification ×200. Inset demonstrates low expression of clusterin in cloning chondrocytes. Magnification
×400. (D) In advanced osteoarthritic cartilage with deep fissuring and proteoglycan loss, clusterin mRNA expression was reduced in all
chondrocytes compared to early osteoarthritic cartilage. Magnification ×200. Inset demonstrates cloning chondrocytes. Magnification ×400.
Osteoarthritis and Cartilage Vol. 9, No. 8 735Lastly, advanced osteoarthritic cartilage was deeply
fissured and had extensive proteoglycan loss. Chondrocyte
cloning was observed in the upper mid-zone of these
tissues. In advanced osteoarthritic cartilage, the cloning
chondrocytes of the upper mid-zone had low levels of
expression of clusterin mRNA [Fig. 4(c), (d)]. Lower mid-
zone and deep zone chondrocytes had negligible levels of
clusterin mRNA (Table II).Discussion
For the first time, we report that clusterin is expressed at
high levels in human cartilage cDNA libraries. Its expres-
sion level was comparable to other genes more commonly
associated with cartilage, such as cartilage oligomeric
protein (COMP), decorin and aggrecan. Although its
physiological function is unclear, this high level of expres-
sion suggests that clusterin plays an important role in the
maintenance or repair of human articular cartilage. This is
the first report of high level clusterin expression in human
chondrocytes. Hogasen et al.5 reported the presence of
clusterin in plasma and synovial fluid from patients with
OA. However, the tissue source of the clusterin was not
identified. In human tissues, Aronow et al.4 demonstrated
by in situ hybridization the expression of clusterin mRNA in
synovial cells of a single hip joint; however, the study did
not compare expression in various disease states.
By TaqMan quantitative PCR analysis of normal human
tissues, clusterin was expressed at high levels in human
brain, liver, adipose, pancreas and cartilage. These data
are in agreement with previous reports where the expres-
sion of clusterin has been detected in a wide variety of
tissues, particularly in brain and liver1,3. The tissue screen-
ing analyses for clusterin expression have not included
cartilage tissue, therefore, our data are unique in this
regard.
A common feature of clusterin in all tissues studies is its
induction in disease states and tissue injury2. In this study,
by microarray, ATLAS blot and in situ hybridization analy-
ses, clusterin was demonstrated to be up-regulated in
cartilage in the early stages of osteoarthritic disease.
Although the mechanism for this induction of expression is
unclear, several lines of evidence suggest possible mech-
anisms. Recent work by Urbich et al.13 has demonstrated
that shear stress caused an up-regulation of clusterin
expression in human umbilical vein endothelial cells.
This increased clusterin provided protection against
complement-induced damage to these cells13. In articular
cartilage, the level of shear stress within the cartilage
matrix is dependent on an intact proteoglycan structure14.
Because changes in proteoglycan integrity are hallmarks of
osteoarthritic disease, it is possible that the resulting
changes in shear stress are responsible for the increased
expression of clusterin observed in the study.
Another possible mechanism of induction of clusterin in
osteoarthritic cartilage is through oxidative stress. Cells
subjected to oxidative stresses (hydrogen peroxide, super-
oxide anion, hyperoxia and UVA exposure) responded with
a strong increase in clusterin mRNA. Additionally, when the
same cell line was transfected with antisense clusterin the
cells were rendered susceptible to apoptosis15. The role of
oxygen intermediates in arthritic cartilage matrix degrada-
tion has been proposed. It has been demonstrated that
articular chondrocytes are capable of producing hydrogen
peroxide16 and it has been proposed that free-radicals may
contribute to depolymerization of hyaluronic acid and evenpossibly proteoglycan breakdown with disease progres-
sion. In contrast, studies have also demonstrated no effect
on chondrocyte metabolism when the cartilage explants
were cultured under anaerobic conditions17. Nevertheless,
the induction of clusterin by oxidative stresses in the
arthritic disease process may be an attempt by the
chondrocytes to defend against damage.
It has been reported recently that TGF regulates the
expression of clusterin through the transcription factor
c-fos18. The study demonstrated that c-fos acts as a
repressor of clusterin expression. In our studies, microarray
analysis of gene expression in normal vs early-
osteoarthritic cartilage showed a five-fold decrease in c-fos
expression. This decrease in c-fos may secondarily result
in an increase in clusterin gene expression. Furthermore,
TGF- is capable of stimulating both collagen and proteo-
glycan synthesis in chondrocytes and increases in type II
collagen expression have been observed in early OA19.
Therefore, TGF- may signal through the chondrocyte to
decrease c-fos production, increase matrix biosynthesis
and increase clusterin expression, in an attempt to maintain
chondrocyte viability and extracellular matrix, early in the
OA process.
French et al.20 have demonstrated that following
exposure to UV-B irradiation, only surviving, morphologi-
cally normal cells express clusterin. Conversely, cells dis-
playing the markers of programmed cells death showed a
marked decrease or absence of clusterin gene expres-
sion20. These observations are in agreement with the
decreased expression of clusterin in cartilage with very
advanced stages of osteoarthritic disease. Chondrocyte
apoptosis has been reported to be elevated in late stage
OA21. Furthermore, there is evidence of apoptotic cells
within chondrocyte clones in osteoarthritic cartilage. By in
situ hybridization, deeply fissured cartilage with cloning
chondrocytes and major proteoglycan loss had decreased
clusterin expression compared with normal and early
osteoarthritic cartilage. This data suggests that as the
disease progresses, clusterin expression is reduced. Loss
of this ‘protector’ molecule may in turn allow for chondro-
cyte apoptosis to occur, possibly driven by the degraded
cartilage matrix22,23.
The chronic degenerative nature of OA suggests that the
cascade of gene expression within the tissue may change
dramatically with progression of the disease. By including
early osteoarthritic cartilage in our analysis, we have seen
differences in expression patterns of some proteins
reported in the literature for more advanced stages of the
disease. By microarray analysis of early osteoarthritic vs
normal cartilage, the upregulation of clusterin mRNA
expression was accompanied by up-regulation of -1 col-
lagen type I. This data is in contrast to a recent report by
Aigner et al.24 in which -1 collagen type I was not detected
in human osteoarthritic cartilage by in situ hybridization.
The difference may be due to a difference in the disease
severity of the tissue samples studied or to a difference in
the relative sensitivity between microarray and in situ
hybridization analysis. Although other collagen types were
not represented on the microarray grid used for the studies
presented here, collagen type I and type II (data not shown)
as well as other collagen types were detected in the human
cartilage cDNA libraries12. In the same microarray analysis,
fibronectin mRNA was down-regulated in early osteo-
arthritic vs normal cartilage. Fibronectin protein has been
reported previously to be increased in OA when analysed
by protein synthesis in explant cultures or by immunohisto-
chemical methods25,26,27; however, the OA was very
736 J. R. Connor et al.: Clusterin expression in human cartilageadvanced in these studies. Another study reported no
increased synthesis of fibronectin in human osteoarthritic
vs normal cartilage; however, they did report greater reten-
tion of fibronectin in osteoarthritic cartilage28. Recently,
Rencic et al.29 reported increased fibronectin mRNA in
advanced osteoarthritic vs normal cartilage. We have also
reported up-regulation of fibronectin in the human osteoar-
thritic cartilage cDNA library which was constructed with
RNA from both early and advanced osteoarthritic tissue12.
Finally, the microarray analysis demonstrated a decrease in
annexin II mRNA expression in early osteoarthritic vs
normal cartilage. This is in contrast to a recent report by
Kirsch et al.30 in which increased annexin II protein was
detected in early and late stage human OA by immuno-
histochemical analysis. This may represent a difference in
analysis of protein vs mRNA expression. Additional analy-
ses would be required to adequately profile the expression
pattern of this gene.
In summary, the data characterize the expression
pattern of clusterin mRNA in adult human normal, early and
advanced osteoarthritic cartilage. The increased expres-
sion of clusterin mRNA in the early stages of OA may reflect
an attempt by the chondrocytes to protect and repair the
tissue. In contrast, the decrease in clusterin mRNA and loss
of this protection in the advanced osteoarthritic cartilage
accompanies the final degenerative stages of the disease.
Although the complete function of clusterin in cartilage
maintenance remains to be determined, an understanding
of the expression of clusterin in OA may allow consideration
of this protein as a marker for cartilage changes in this
chronic degenerative condition.Acknowledgments
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